Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity

PURPOSE: To investigate the association between body composition parameters, sarcopenia, obesity and prognosis in patients with metastatic ER+/HER2- breast cancer under therapy with cyclin-dependent kinase (CDK) 4/6 inhibitors. METHODS: 92 patients with biopsy-proven metastatic ER+/HER2- breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kripa, Endi, Rizzo, Veronica, Galati, Francesca, Moffa, Giuliana, Cicciarelli, Federica, Catalano, Carlo, Pediconi, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538503/
https://www.ncbi.nlm.nih.gov/pubmed/36212446
http://dx.doi.org/10.3389/fonc.2022.987012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538503/
https://www.ncbi.nlm.nih.gov/pubmed/36212446
http://dx.doi.org/10.3389/fonc.2022.987012

Ejemplares similares